The present study was carried out to investigate the toxic effects of the Oxalis barrelieri aqueous aerial parts extract. Place and Duration of Study: Materials and Methods: Acute toxicity using a single dose of 2000 mg/kg was administered to mice and effects were observed for 14 days. In sub-acute toxicity, the experimental rats (males and Mezui et al.; JABB, 22(2): 1-13, 2019; Article no.JABB.46165 2 females) received aqueous extract of Oxalis barrelieri at doses of 200 mg/kg, 400 mg/kg and 800 mg/kg daily for 28 days while the control and satellite control groups received distilled water and satellite test group received extract at the dose of 800 mg/kg. The physical parameters were evaluated throughout the treatment, while the haematological, biochemical and histological parameters were evaluated at the end of the treatment. Results: In acute toxicity, the results obtained show no death and no significant variation (p>0.05) in behavioral and morphological parameters. In sub-acute toxicity assay, few modifications were observed in haematological and biochemical parameters. At the higher dose of extract (800 mg/kg),the rate of red blood cells decreased significantly (p<0.05) two weeks after treatment in male rats , there were a significant increase (P˂0.001) in ASAT activity in male and female rats two weeks after extract administration, and a reversible significant increase (P˂0.05) in triglyceride level in male rats only. Histopathology showed a reversible slight dose dependent structural alteration of the kidney and reversible vascular congestion in liver. Conclusion: The aqueous aerial parts extract of Oxalis barrelieri could possess moderate toxicity at high doses and adequate caution should be exercised in its use in ethnomedicine.
INTRODUCTION
Oxalis is a cosmopolitan genus of more than 800 species, but major centers of diversity are in South America and South Africa.
Oxalis barrelieri (synonym: O. sepium) is native to tropical South America, but has naturalized in many areas. It was first observed in Java in 1888. In South-East Asia it is common in Indonesia (Sumatra, Bangka, Java, Irian Jaya), Peninsular Malaysia, and Papua New Guinea [1] . Oxalis barrelieri is a ruderal, annual upright herb up to 60 cm tall found on sandy, acid soils [2] . O. barrelieri is a highly nectariferous and highly pollinating apiculture plant [3] . Leaves subopposite, pinnately 3-foliolate,without stipules; petiole 2-9 cm long, canaliculate, ascendent; petiolule fleshy, about 1 mm long; leaflet elliptical to oblong, 1-5.5 cm x 0.5-2.5 cm, terminal one largest, base cuneate to emarginate, margin ciliate (especially at base), apex obtuse to rounded, discolorous, glaucous above. Inflorescence cymose, up toll(-30)flowered; peduncle up to 6.5 cm long, bifid with branches up to 3 cm long, pubescent; bracts opposite the pedicels, pilose; pedicel up to 3 mm long with appressed bracteoles; sepals ovate lanceolate, 2-4 mm x 0.5-1.5 mm, light green, sometimes reddish veined; petals obovatelanceolate, 6-9 mm x 2-2.5 mm, pink but lower half greenish with yellow spots, rolling inwards after anthesis; outer stamens up to 2 mm long, inner ones up to 3 mm long bearing a dorsal tooth; pistil 3.5-4 mm long, carpels 3-4-ovuled, styles 1-1.5 mm long, pubescent. Capsule ovoid, 5-10 mm x 3-5 mm, 5-angular, base and apex 5lobed, glabrous. Seeds usually 3 per carpel flatten edovoid, about 1.5-2 mm x 1 mm, 8-ribbed in zigzag, deeply transversely striate, brownish [1, 4] . O. barrelieri is known as "belimbing tanah" in Malaysia, as "Tetele owono bekon" in South Cameroon. O. barrelieri has been claimed to have effect on antifungal and free radical scavenging activities [5] . Enoch et al. [6] reported that administration of 500 mg/kg and 1000 mg/kg aqueous and ethanolic extracts of O. barrelieri on Sprague-dawley rats produced significant reductions of glycemia in both non-diabetic and diabetic rats. A decoction of the entire plant is used for the treatment of diarrhea [7, 8] . O. barrelieri is rich in phenols, flavonoïds, tannins, alkaloids and saponins [9] . However, the toxicity of Oxalis barrelieri has not been intensively studied in order to ascertain the limits of it application. The aim of this study was to investigate the acute and sub-acute toxicity effects of the aqueous aerial parts extract of this plant.
MATERIALS AND METHODS

Plant Collection, Identification and Extract Preparation
The leaves of Oxalis barrelieri were harvested in April 2017 at Yaoundé, in the Center Region of Cameroon. Botanical identification was done in the National Herbarium, Yaounde, by Paul MEZILI, by comparing with existing herbarium specimen no. 24509. The aerial parts of Oxalis barrelieri were dried at room temperature. The dried ground aerial parts of Oxalis barrelieri were extracted in distilled water by boiling 168 g in 4.18 L of water for 15 minutes and the extract solution was filtered using Wattman filter paper no 3. The filtrate was lyophilized and the resulting solid was used for the toxicity tests. The resulting material weighed 34.44 g, giving a percentage yield of 20.52% with respect to the powder. The extract re-dissolved readily in distilled water which was used as the vehicle.
Experimental Animals
Female Swiss mice weighing 23 ± 3 g (10 ± 2 weeks) were used for acute toxicity ,and male and female young Wistar rats weighing 78 -120 g (6 to 8 weeks) for sub acute toxicity. These animals were raised in the Animal house of the Higher Teachers' Training College, University of Yaoundé I. They were fed a standard laboratory died (NAAPCAM Sarl, Yaoundé, Cameroon) and given fresh water ad libitum. Before the experiments (acute toxicity), they were starved for 12 h in wire mesh bottom cages to prevent coprophagy but allowed free access to water. Prior authorization for the use of Laboratory Animals was obtained from the Cameroon National Ethics Committee (Reg. Nº FWAIRB00001954). The use, handling and care of animals were done in adherence to the European Convention (Strasbourg, 18.III.1986) for the protection of vertebrate animals used for experimental and other purposes (ETS-123), with particular attention to Part III, articles 7, 8 and 9.
Acute Toxicity
The acute toxicity was performed according to the sequential method of OECD (Organization for Economic Co-operation and Development). Using a stomach tube, the O. barreleri extract was administered to three female mice (20 -26 g) with a single dose (2000 mg/kg). The control group received vehicle. The same method and the same dose were repeated 48 hours later, on 3 additional animals. Thereafter, all animals were observed carefully for 14 days during which mortality, body weights and gross behavioral change were noted daily [10] .
Sub Acute Toxicity
Young Wistar rats (78-120 g) in six groups of 12 animals (6 males and 6 females) for each dose level of Oxalis barrelieri were used in these tests. Sub acute toxicity was evaluated after single daily administration of extract at 200, 400 and 800 mg/kg orally for a period of 4 weeks.
The satellite group was also treated with the extract of Oxalis barrelieri (800 mg/kg) for 4 weeks but these animals were sacrificed 2 weeks after stopping treatment. The satellite control and control group received vehicle. Satellite control was sacrificed 2 weeks after treatment. All rats were maintained under identical conditions with food and water ad libitum for the entire period with close observation. Toxicity was evaluated in terms of corporal and organ weights (heart, kidney, liver, spleen, lungs, ovaries and testicles), gross behavior, gross and histological appearance of detoxification organs (kidney and liver). The plasma from EDTA blood prepared was carefully collected for blood chemistry and enzyme analysis (total protein, AST, ALT, creatinine, urea, total cholesterols and triglycerides) using Commercial kits (Fortress) and glycaemia using a glucometer (One Touch Ultra). The Haematological parameters (white blood cell count, red blood cell count, platelet count, hemoglobin, haematocrit, Medium Globular Volume (MGV), Average Corpuscle Concentration in Hemoglobin(ACCH), Average Volume of Platelets (AVP), Thrombocritis (THT), Average Corpuscle Content in Hemoglobin (ACCh) and Red Blood Cell Distribution Index (RDI) were evaluated using a Coulter counter [10, 11, 12 ].
Statistical Analysis
The results were reported as mean ± SEM. The statistical significance was determined by using one way analysis of variance (ANOVA) followed by Tukey multiple comparison tests. P values less than 0.05 were considered as significant.
RESULTS
Acute Toxicity
Administration of a single dose of aqueous extract of Oxalis barrelieri (2000 mg/kg) in mice did not result in any deaths in the first stage. 48 hours later, carrying out a second test did not result in any deaths. After 14 days of observation, no changes were observed in mice regarding: coat color, appearance, saddles, reflexes, alertness, heart rate, respiratory rate, sensitivity to noise, sensitivity to touch and body weight ( Tables 1 and 2 ). The aqueous extract of Oxalis barrelieri is classified in category 5 which includes substances with LD 50 is greater than 2000 mg/kg, according to OECD guideline 423, 2001. 
-Parameter absent; + Parameter present (Each group contains 3 females)
Sub Acute Toxicity
All rats (male and female) treated with O. barrelieri extract showed a body weight gain similar to that of control rats. No loss of body weight was observed. Male rats had higher weight gain than female rats (Tables 3 and 4 ). (Table 6 ). Other plasma parameters (glycemia, ALT, total proteins, cholesterol, creatinine) did not show any significant variation.
After four weeks of Oxalis barrelieri extract administration, the rats of the batches receiving doses of 200, 400 and 800 mg/kg presented dose-dependent vascular congestions compared to control group. Observation of liver tissue, fourteen days later, showed complete repair of these vascular congestions (Fig. 1) . Histological section analysis revealed renal tissue damage including enlargement of the glomerular chamber and destruction of nephrons. This alteration is dose-dependent and appears to have worsened two weeks after stopping treatment (Fig. 2) . The analysis also showed that the said alteration is more pronounced in males than in females.
DISCUSSION
Oxalis barrelieri is a medicinal plant used to treat certain pathologies such as diabetes [13] and diarrhea [7, 8] . In this study, the objective was to evaluate the toxic effects of this plant on biological systems, particularly in the liver and kidneys.
The oral administration of a single dose (2000 mg / kg) of Oxalis barrelieri aqueous extract did not cause any significant changes in either the behavior or the physical condition of these animals. Noise and touch sensitivity, coat condition and nature of stool showed no significant variation (Table 1) . No deaths were observed during 14 (fourteen) days of observation. In addition, the body weight of the mice treated with O. barrelieri extract did not undergo any significant variation ( [16, 17] . So this extract would be slightly toxic.
Blood is one of the targets of the body most attacked by toxic substances, it provides important informations on the physiology and pathologies of animals [18] .Haematological parameters give informations on hematopoietic function (evaluation of cells of the myeloid lineage) and the determination of the occurrence of any allergies (white blood cell studies) [19] . Blood parameter analysis in rodents can provide a high predictive index (up to 91% concordance)
for risk of toxicity in humans [20] . Extract of O. barrelieri (800 mg/kg) resulted in a significant (p <0.05) decrease in red blood cell counts in male rats two weeks after treatment discontinuation (satellite test group). In female rats, O. barrelieri extract (200 mg/kg) caused a significant (p <0.05) non-dose-dependent increase in red blood cell count ( Table 6 ). The decrease in red blood cell count observed in male rats two weeks after discontinuation showed that O. barrelieri extract (800 mg/kg) was transformed into a metabolite that inhibited hematopoiesis. These results are close to those of Raphia hookeri extract [21] . These toxic effects of the O. barrelieri aqueous extract are due to chemical composition. O. barrelieri extract is rich in phenols, flavonoïds, tannins, alkaloids and saponins [9] . Saponins have deleterious effects on red blood cells and inhibit the proliferation of erythrocytes in bone marrow [22, 23] . In addition, tannins cause loss of appetite in animals [24] ; alkaloids would have teratogenic effects [25] .
Serum biochemical parameters are used to evaluate the effects of xenobiotics on liver and kidney function. The liver is prone to xenobioticinduced injury because of its central role in xenobiotic metabolism, its portal location within the circulation and its anatomical and physiological structure. The study of fasting blood glucose gives information on the state of functioning of the liver and pancreas. However, the liver provides storage and release while the pancreas information on the availability and deficiency [26] . No significant variation was observed in animals treated with the extract of O. barrelieri. This result indicates that this extract does not change the functioning of the liver and pancreas. Generally, analysis of the activities of some basic liver enzymes (such as ALAT and ASAT) in the plasma or serum can be used to indirectly assess the integrity of tissues after being exposed to certain pharmacological agents [27] . Necrosis or membrane damage releases the enzymes into circulation; therefore, it can be measured in the serum. Usually, about 80% of ASAT is found in the mitochondria whereas ALAT is a purely cytosolic enzyme. Therefore, ASAT appears in higher concentrations in a number of tissues (liver, kidneys, heart and pancreas) and is released slowly in comparison to ALAT. But since ALAT is localized primarily in the cytosol of hepatocytes, this enzyme is considered a more sensitive marker of liver inflammation or damage than ASAT and within limits can provide a quantitative assessment of the degree of damage sustained by the liver [28] . O. barrelieri extract at 800 mg / kg resulted in a significant (p <0.05) increase in ASAT activity in female rats. Two weeks after stopping the administration of the extract, ASAT activity significantly (p <0.001) increased in both female and male rats ( Table 7) . This result would suggest that this extract and its metabolites would cause alteration of the liver or other organs such as kidney, heart, pancreas or muscles.
The lipid profile is an indicator of lipid metabolism in the liver [29] . The increase in serum triglyceride levels is due to liver dysfunction and may cause cardiovascular problems. Triglycerides increased significantly (P <0.01) in male rats treated with the extract (800 mg/kg), this effect disappear in the two weeks following discontinuation of therapy (Table 7) . This result would suggest that the O. barrelieri extract might disturb hepatic lipid metabolism and cause cardiovascular problems, but this effect is reversible. Estimation of total protein is one of the most widely used means of measuring hepatocellular injury. Total protein measurements can reflect nutritional status and may be used to screen for and help diagnose kidney disease, liver disease, and many other conditions. Low total protein levels can suggest a liver disorder, a kidney disorder, or a disorder in which protein is not digested or absorbed properly. High total protein levels may be seen with chronic inflammation or liver infections. Total cholesterol test is used to estimate risk of developing disease (specifically cardio-vascular disease) and some liver dysfunctions. Increase in the total protein and cholesterol as well would have indicated hepatocyte damage [30] . There were no significant changes in serum lipid profile (cholesterol) as compared to the control groups. This result suggests the absence of major cardiovascular risks factors induced by O. barrelieri extract.
The kidneys are highly susceptible to toxicants for two reasons; a high volume of blood flows through it and its ability to filter large amounts of toxins which can concentrate in the kidney tubules. It can result in systemic toxicity causing decreased ability to excrete body wastes, inability to maintain body fluid and electrolyte balance and decreased synthesis of essential hormones. Blood urea nitrogen is derived in the liver protein/amino acid from dietary or tissue sources and is normally excreted in the urine. In renal disease, serum urea accumulates because the rate of serum urea production exceeds the rate of clearance [31] . Creatinine, on the other hand, is mostly derived from endogenous sources by tissue creatine breakdown. The plasma creatinine concentrations in normal individuals are usually affected by a number of factors such as the muscle mass, high protein diet and catabolic state, thus serum urea concentration is often considered the more reliable renal function predictor than serum creatinine [32] . There were no significant changes in the levels of serum creatinine in the treated groups compared with the controls. O. barrelieri extract (800 mg / kg) increased significantly (p <0.05) the urea level that normalized in the two following treatment discontinuation ( Table 7) . These results would suggest that the extract would have reversible deleterious effects on the kidney.
Liver tissue analysis of animals treated with the O. barrelieri aqueous extract suggests the presence of structural abnormalities. Hepatic vein congestion was observed in all rats given the aqueous extract of O. barrelieri at all doses. Liver congestion could be attributed, in part, to its role in biotransformation of xenobiotics [33] . However, within two weeks of stopping the extract administration, this anomaly was normalized. This would suggest that hepatic vein congestion induced by O. barrelieri aqueous extract is reversible (Fig. 1 ). This would suggest that the liver has put in place self-healing mechanisms. Kidney histology revealed the enlargement of glomerular chamber in the 800 mg / kg (male rats) and satellite groups male and female rats). These observations suggest that high doses of O. barrelieri extract would induced renal tissue damage because the rats treated with the extract (200 mg / kg or 400 mg/kg) showed no structural abnormality on the renal tissue (Fig. 2) .
CONCLUSION
Our study shows that the LD 50 of the O. barrelieri extract is greater than 2000 mg/kg, so this extract is classified as poorly toxic substances. A study with three dose levels (200 mg/kg, 400 mg/kg and 800 mg/kg) administered daily to the animals, for 28 days period, showed some abnormalities of the hematological and serum parameters. In addition, the hepatic vascular congestion observed was reversible whereas the dilation of the renal glomerular chamber is not. These effects were more pronounced at the 800 mg/kg extract dose. Further investigations need to be done for the complete elucidation of the safety profile of O. barrelieri.
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